Second Nitrosamine Implementation Oversight Group (NIOG) - meeting with pharmaceutical industry
Date:
08/12/2021
Location:
Online
The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.
The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.
This is the second meeting of the NIOG with industry stakeholders. The aim is to provide an update on progress of NIOG workplan and discuss priorities for 2022.
-
List item
Agenda - Nitrosamine Implementation Oversight Group (NIOG) - second meeting with pharmaceutical industry (PDF/135.87 KB)
Adopted
First published: 17/12/2021
EMA/535229/2021 -
List item
Highlights from the second meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry (PDF/113.74 KB)
First published: 17/12/2021
EMA/711797/2021 -
List item
Presentation - Nitrosamine Implementation Oversight Group (NIOG) - second meeting with pharmaceutical industry (PDF/427.54 KB)
First published: 17/12/2021 -
List item
Presentation - Industry stakeholder supporting presentation (PDF/566.75 KB)
First published: 17/12/2021